HCW Biologics Inc. (HCWB) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 2.03M |
| Enterprise Value | 6.89M |
| P/E Ratio | -0.1 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0.11 |
| Price/Book Ratio | 0.33 |
| Enterprise/Revenue | 0.98 |
| Enterprise/EBITDA | -1.54 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -0.73 |
| Operating Margin | -0.92 |
| Return On Assets | -0.18 |
| Return On Equity | -1.42 |
| Revenue | 54,232 |
| Revenue/Share | 6.02 |
| Gross Profit | 10,846 |
| EBITDA | -5.67M |
| Net Income | -7.96M |
| Diluted EPS | -63.78 |
| Total Cash | 741,324 |
| Total Cash/Share | 0.66 |
| Total Debt | 6.56M |
| Total Debt/Equity | 0.88 |
| Current Ratio | 0.06 |
| Book Value Per Share | 6.65 |
| 52-Week Change | -89.47 |
| 52-Week High | 44.1 |
| 52-Week Low | 1.5 |
| Moving Average 50 Days | 4.26 |
| Moving Average 200 Days | 6.5 |
| Average Volume | 161,232 |
| Shares Outstanding | 347,641 |
| % Held by Institutions | 21.44 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:6 |
| Last Split Date | June 30, 2026 |